Lupin has launched Ethacrynic Acid Tablets USP, 25 mg, having received an approval from the United States Food and Drug Administration (USFDA) earlier. The product would be manufactured at Lupin's Nagpur OSD facility, India.
Ethacrynic Acid Tablets USP, 25 mg, is the generic equivalent of Edecrin Tablets, 25 mg, of Bausch Health Americas Inc. and are indicated for the treatment of edema when an agent with greater diuretic potential than those commonly employed is required.
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.
